Letko Brosseau & Associates Inc. cut its holdings in LifePoint Health, Inc. (NASDAQ:LPNT) by 1.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,345,929 shares of the company’s stock after selling 19,145 shares during the quarter. Letko Brosseau & Associates Inc. owned about 3.36% of LifePoint Health worth $90,379,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in LPNT. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares during the last quarter. LS Investment Advisors LLC raised its stake in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares during the last quarter. US Bancorp DE raised its stake in LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares during the last quarter. Bank of Montreal Can raised its stake in LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in LifePoint Health in the first quarter valued at about $210,000. Institutional investors own 99.53% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “LifePoint Health, Inc. (LPNT) Shares Sold by Letko Brosseau & Associates Inc.” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/14/lifepoint-health-inc-lpnt-shares-sold-by-letko-brosseau-associates-inc.html.

Shares of LifePoint Health, Inc. (LPNT) traded up 1.463% during mid-day trading on Thursday, reaching $57.225. The company’s stock had a trading volume of 150,097 shares. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of 12.813 and a beta of 0.85. The company’s 50 day moving average price is $57.97 and its 200-day moving average price is $62.11. LifePoint Health, Inc. has a 1-year low of $50.60 and a 1-year high of $70.95.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm’s revenue was up .2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.69 EPS. Analysts predict that LifePoint Health, Inc. will post $4.06 earnings per share for the current fiscal year.

A number of equities research analysts have commented on LPNT shares. Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research note on Wednesday, July 5th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a research note on Tuesday, July 4th. BidaskClub upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Finally, TheStreet cut LifePoint Health from a “b-” rating to a “c+” rating in a research note on Wednesday, August 16th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $66.18.

In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the completion of the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 7.28% of the stock is owned by corporate insiders.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.